tirzepatide uses and side effects dosage chart in units: complete conversion guide for every concentration Understanding Tirzepatide Side Effects, Risks

Ozempic (semaglutide) was approved by the FDA in December 2017 for type 2 diabetes, and in 2021 the company introduced a higher-dose version of semaglutide, branded as Wegovy, that was approved specifically for weight management

Beyond GI effects, clinical trials documented dose-dependent heart rate increases that peaked at approximately 24 weeks and then declined

DOI: 10.1001/jamacardio.2025.1095 Never miss a breakthrough: Join the SciTechDaily newsletter

We perform routine lab tests to assess kidney function, monitor symptoms, and adjust treatments as needed

PMID: 11932302

First approved in 2021 for weight management, Wegovy has delivered DKK21.7 billion ($3.1 billion) in revenues to Novo over the first nine months of 2023